[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Glucagon like peptide-1 (GLP-1) agonists Market Report 2016

November 2016 | 107 pages | ID: E6AB9437878EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Glucagon like peptide-1 (GLP-1) agonists

Revenue, means the sales value of Glucagon like peptide-1 (GLP-1) agonists

This report studies sales (consumption) of Glucagon like peptide-1 (GLP-1) agonists in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Novo Nordisk
  • AstraZeneca
  • Eli Lilly
  • GSK
  • Sanofi
  • Bristol-Myers Squibb
  • Amylin
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Glucagon like peptide-1 (GLP-1) agonists in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Exenatied
  • Liraglutide
  • Lixisenatide
  • Abliglutide
  • Dulaglutide
Split by application, this report focuses on sales, market share and growth rate of Glucagon like peptide-1 (GLP-1) agonists in each application, can be divided into
  • Hospital
  • Pharmacy
  • Application 3
Europe Glucagon like peptide-1 (GLP-1) agonists Market Report 2016

1 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS OVERVIEW

1.1 Product Overview and Scope of Glucagon like peptide-1 (GLP-1) agonists
1.2 Classification of Glucagon like peptide-1 (GLP-1) agonists
  1.2.11 Exenatied
  1.2.12 Liraglutide
  1.2.13 Lixisenatide
  1.2.14 Abliglutide
  1.2.15 Dulaglutide
1.3 Application of Glucagon like peptide-1 (GLP-1) agonists
  1.3.11 Hospital
  1.3.12 Pharmacy
  1.3.3 Application
1.4 Glucagon like peptide-1 (GLP-1) agonists Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Glucagon like peptide-1 (GLP-1) agonists (2011-2021)
  1.5.1 Europe Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2021)
  1.5.2 Europe Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)

2 EUROPE GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Glucagon like peptide-1 (GLP-1) agonists Market Competition by Manufacturers
  2.1.1 Europe Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Glucagon like peptide-1 (GLP-1) agonists Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Glucagon like peptide-1 (GLP-1) agonists (Volume and Value) by Type
  2.2.1 Europe Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Type (2011-2016)
2.3 Europe Glucagon like peptide-1 (GLP-1) agonists (Volume and Value) by Countries
  2.3.1 Europe Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Countries (2011-2016)
2.4 Europe Glucagon like peptide-1 (GLP-1) agonists (Volume) by Application

3 GERMANY GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2011-2016)
  3.1.1 Germany Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
  3.1.2 Germany Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
3.2 Germany Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Manufacturers
3.3 Germany Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type
3.4 Germany Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Application

4 FRANCE GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

4.1 France Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2011-2016)
  4.1.1 France Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
  4.1.2 France Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
  4.1.4 France Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
4.2 France Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Manufacturers
4.3 France Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type
4.4 France Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Application

5 UK GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2011-2016)
  5.1.1 UK Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
  5.1.2 UK Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
  5.1.5 UK Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
5.2 UK Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Manufacturers
5.3 UK Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type
5.4 UK Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Application

6 RUSSIA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2011-2016)
  6.1.1 Russia Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
  6.1.2 Russia Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
6.2 Russia Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Manufacturers
6.3 Russia Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type
6.4 Russia Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Application

7 ITALY GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2011-2016)
  7.1.1 Italy Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
  7.1.2 Italy Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
7.2 Italy Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Manufacturers
7.3 Italy Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type
7.4 Italy Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Application

8 SPAIN GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2011-2016)
  8.1.1 Spain Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
  8.1.2 Spain Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
8.2 Spain Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Manufacturers
8.3 Spain Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type
8.4 Spain Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Application

9 BENELUX GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2011-2016)
  9.1.1 Benelux Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
9.2 Benelux Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Manufacturers
9.3 Benelux Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type
9.4 Benelux Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Application

10 EUROPE GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURERS ANALYSIS

10.1 Novo Nordisk
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 AstraZeneca
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Eli Lilly
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Eli Lilly Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 GSK
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 GSK Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Sanofi
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Sanofi Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Bristol-Myers Squibb
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Amylin
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Amylin Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview

11 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURING COST ANALYSIS

11.1 Glucagon like peptide-1 (GLP-1) agonists Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Glucagon like peptide-1 (GLP-1) agonists Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET FORECAST (2016-2021)

14.1 Germany Glucagon like peptide-1 (GLP-1) agonists Sales Forecast (2016-2021)
14.2 France Glucagon like peptide-1 (GLP-1) agonists Sales Forecast (2016-2021)
14.3 UK Glucagon like peptide-1 (GLP-1) agonists Sales Forecast (2016-2021)
14.4 Russia Glucagon like peptide-1 (GLP-1) agonists Sales Forecast (2016-2021)
14.5 Italy Glucagon like peptide-1 (GLP-1) agonists Sales Forecast (2016-2021)
14.6 Spain Glucagon like peptide-1 (GLP-1) agonists Sales Forecast (2016-2021)
14.7 Benelux Glucagon like peptide-1 (GLP-1) agonists Sales Forecast (2016-2021)
14.8 Europe Glucagon like peptide-1 (GLP-1) agonists Sales Forecast by Type (2016-2021)
14.9 Europe Glucagon like peptide-1 (GLP-1) agonists Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Glucagon like peptide-1 (GLP-1) agonists
Table Classification of Glucagon like peptide-1 (GLP-1) agonists
Figure Europe Sales Market Share of Glucagon like peptide-1 (GLP-1) agonists by Type in 2015
Figure Exenatied Picture
Figure Liraglutide Picture
Figure Lixisenatide Picture
Figure Abliglutide Picture
Figure Dulaglutide Picture
Table Application of Glucagon like peptide-1 (GLP-1) agonists
Figure Europe Sales Market Share of Glucagon like peptide-1 (GLP-1) agonists by Application in 2015
Figure Hospital Examples
Figure Pharmacy Examples
Figure Germany Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)
Figure France Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)
Figure UK Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)
Figure Russia Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)
Figure Italy Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)
Figure Spain Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)
Figure Benelux Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)
Figure Europe Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2021)
Figure Europe Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Sales of Key Manufacturers (2015 and 2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Glucagon like peptide-1 (GLP-1) agonists Sales Share by Manufacturers
Figure 2016 Glucagon like peptide-1 (GLP-1) agonists Sales Share by Manufacturers
Table Europe Glucagon like peptide-1 (GLP-1) agonists Revenue by Manufacturers (2015 and 2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Manufacturers
Table 2016 Europe Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Manufacturers
Table Europe Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type (2011-2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Sales Share by Type (2011-2016)
Figure Sales Market Share of Glucagon like peptide-1 (GLP-1) agonists by Type (2011-2016)
Figure Europe Glucagon like peptide-1 (GLP-1) agonists Sales Growth Rate by Type (2011-2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Type (2011-2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Type (2011-2016)
Figure Europe Glucagon like peptide-1 (GLP-1) agonists Revenue Growth Rate by Type (2011-2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Countries (2011-2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Sales Share by Countries (2011-2016)
Figure Sales Market Share of Glucagon like peptide-1 (GLP-1) agonists by Countries (2011-2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Countries (2011-2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Countries (2011-2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Application (2011-2016)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Sales Share by Application (2011-2016)
Figure Sales Market Share of Glucagon like peptide-1 (GLP-1) agonists by Application (2011-2016)
Figure Germany Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
Figure Germany Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
Figure Germany Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
Table Germany Glucagon like peptide-1 (GLP-1) agonists Sales by Manufacturers (2015 and 2016)
Table Germany Glucagon like peptide-1 (GLP-1) agonists Market Share by Manufacturers (2015 and 2016)
Table Germany Glucagon like peptide-1 (GLP-1) agonists Sales by Type (2015 and 2016)
Table Germany Glucagon like peptide-1 (GLP-1) agonists Market Share by Type (2015 and 2016)
Table Germany Glucagon like peptide-1 (GLP-1) agonists Sales by Application (2015 and 2016)
Table Germany Glucagon like peptide-1 (GLP-1) agonists Market Share by Application (2015 and 2016)
Figure France Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
Figure France Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
Figure France Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
Table France Glucagon like peptide-1 (GLP-1) agonists Sales by Manufacturers (2015 and 2016)
Table France Glucagon like peptide-1 (GLP-1) agonists Market Share by Manufacturers (2015 and 2016)
Table France Glucagon like peptide-1 (GLP-1) agonists Sales by Type (2015 and 2016)
Table France Glucagon like peptide-1 (GLP-1) agonists Market Share by Type (2015 and 2016)
Table France Glucagon like peptide-1 (GLP-1) agonists Sales by Application (2015 and 2016)
Table France Glucagon like peptide-1 (GLP-1) agonists Market Share by Application (2015 and 2016)
Figure UK Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
Figure UK Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
Figure UK Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
Table UK Glucagon like peptide-1 (GLP-1) agonists Sales by Manufacturers (2015 and 2016)
Table UK Glucagon like peptide-1 (GLP-1) agonists Market Share by Manufacturers (2015 and 2016)
Table UK Glucagon like peptide-1 (GLP-1) agonists Sales by Type (2015 and 2016)
Table UK Glucagon like peptide-1 (GLP-1) agonists Market Share by Type (2015 and 2016)
Table UK Glucagon like peptide-1 (GLP-1) agonists Sales by Application (2015 and 2016)
Table UK Glucagon like peptide-1 (GLP-1) agonists Market Share by Application (2015 and 2016)
Figure Russia Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
Figure Russia Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
Figure Russia Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
Table Russia Glucagon like peptide-1 (GLP-1) agonists Sales by Manufacturers (2015 and 2016)
Table Russia Glucagon like peptide-1 (GLP-1) agonists Market Share by Manufacturers (2015 and 2016)
Table Russia Glucagon like peptide-1 (GLP-1) agonists Sales by Type (2015 and 2016)
Table Russia Glucagon like peptide-1 (GLP-1) agonists Market Share by Type (2015 and 2016)
Table Russia Glucagon like peptide-1 (GLP-1) agonists Sales by Application (2015 and 2016)
Table Russia Glucagon like peptide-1 (GLP-1) agonists Market Share by Application (2015 and 2016)
Figure Italy Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
Figure Italy Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
Figure Italy Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
Table Italy Glucagon like peptide-1 (GLP-1) agonists Sales by Manufacturers (2015 and 2016)
Table Italy Glucagon like peptide-1 (GLP-1) agonists Market Share by Manufacturers (2015 and 2016)
Table Italy Glucagon like peptide-1 (GLP-1) agonists Sales by Type (2015 and 2016)
Table Italy Glucagon like peptide-1 (GLP-1) agonists Market Share by Type (2015 and 2016)
Table Italy Glucagon like peptide-1 (GLP-1) agonists Sales by Application (2015 and 2016)
Table Italy Glucagon like peptide-1 (GLP-1) agonists Market Share by Application (2015 and 2016)
Figure Spain Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
Figure Spain Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
Figure Spain Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
Table Spain Glucagon like peptide-1 (GLP-1) agonists Sales by Manufacturers (2015 and 2016)
Table Spain Glucagon like peptide-1 (GLP-1) agonists Market Share by Manufacturers (2015 and 2016)
Table Spain Glucagon like peptide-1 (GLP-1) agonists Sales by Type (2015 and 2016)
Table Spain Glucagon like peptide-1 (GLP-1) agonists Market Share by Type (2015 and 2016)
Table Spain Glucagon like peptide-1 (GLP-1) agonists Sales by Application (2015 and 2016)
Table Spain Glucagon like peptide-1 (GLP-1) agonists Market Share by Application (2015 and 2016)
Figure Benelux Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2016)
Figure Benelux Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2016)
Figure Benelux Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2011-2016)
Table Benelux Glucagon like peptide-1 (GLP-1) agonists Sales by Manufacturers (2015 and 2016)
Table Benelux Glucagon like peptide-1 (GLP-1) agonists Market Share by Manufacturers (2015 and 2016)
Table Benelux Glucagon like peptide-1 (GLP-1) agonists Sales by Type (2015 and 2016)
Table Benelux Glucagon like peptide-1 (GLP-1) agonists Market Share by Type (2015 and 2016)
Table Benelux Glucagon like peptide-1 (GLP-1) agonists Sales by Application (2015 and 2016)
Table Benelux Glucagon like peptide-1 (GLP-1) agonists Market Share by Application (2015 and 2016)
Table Glucagon like peptide-1 (GLP-1) agonists Basic Information List
Table Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table Amylin Basic Information List
Table Amylin Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amylin Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucagon like peptide-1 (GLP-1) agonists
Figure Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists
Figure Glucagon like peptide-1 (GLP-1) agonists Industrial Chain Analysis
Table Raw Materials Sources of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
Table Major Buyers of Glucagon like peptide-1 (GLP-1) agonists
Table Distributors/Traders List
Figure Germany Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Forecast (2016-2021)
Figure Germany Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2016-2021)
Figure France Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Forecast (2016-2021)
Figure France Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2016-2021)
Figure UK Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Forecast (2016-2021)
Figure UK Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Forecast (2016-2021)
Figure Russia Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Forecast (2016-2021)
Figure Italy Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Forecast (2016-2021)
Figure Spain Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2016-2021)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Sales Forecast by Type (2016-2021)
Table Europe Glucagon like peptide-1 (GLP-1) agonists Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories